ASCENDIS PHARMA A/S -
124.33
08-11月-24 14:59:59
15 分の遅延
株式
-2.22
-1.75%
本日の幅
124.11 - 128.20
ISIN
N/A
ソース
NASDAQ
-
07 11 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
04 11 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
30 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
30 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
19 9 2024 19:16:32 提供 Nasdaq GlobeNewswire
-
Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
18 9 2024 15:04:11 提供 Nasdaq GlobeNewswire
-
16 9 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
13 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
11 9 2024 16:37:50 提供 Nasdaq GlobeNewswire
-
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
03 9 2024 16:06:29 提供 Nasdaq GlobeNewswire
-
Ascendis Pharma Reports Second Quarter 2024 Financial Results
03 9 2024 16:04:32 提供 Nasdaq GlobeNewswire
-
28 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
12 8 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
24 6 2024 15:45:36 提供 Nasdaq GlobeNewswire
-
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
04 6 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024
03 6 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024
30 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
14 5 2024 13:31:44 提供 Nasdaq GlobeNewswire
-
09 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >